News tagged with monoclonal antibodies
A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.
Diseases, Conditions, Syndromes 3 hours ago | not rated yet | 0
(HealthDay)—Many pre-term babies suffer recurrent episodes of wheezing. Now, researchers say a common infection is a likely culprit and they may be able to prevent the breathing problems.
Diseases, Conditions, Syndromes May 09, 2013 | not rated yet | 0 |
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
Cancer Apr 19, 2013 | 5 / 5 (2) | 0 |
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.
Cancer Mar 25, 2013 | 5 / 5 (4) | 0 |
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference.
Cardiology Mar 26, 2012 | 5 / 5 (2) | 5
(HealthDay) -- Administration of REGN727, a monoclonal antibody to proprotein convertase subtilisin/kexin 9 (PCSK9), significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to the ...
Cardiology Mar 22, 2012 | 3 / 5 (1) | 1 |
A new Ebola virus study resulting from a widespread scientific collaboration has shown promising preliminary results, preventing disease in infected nonhuman primates using monoclonal antibodies.
Medical research Oct 15, 2012 | 4.8 / 5 (4) | 1 |
A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.
Medical research Aug 20, 2012 | 5 / 5 (1) | 0 |
Researchers develop novel anti-body vaccine that blocks addictive nicotine chemicals from reaching the brain
Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.
Medical research Jun 27, 2012 | 5 / 5 (7) | 7 |
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common—and sometimes very serious—childhood disease. ...
Diseases, Conditions, Syndromes Apr 25, 2013 | not rated yet | 0 |
Advanced cancers destined to recur after treatment with single drugs that 'target' tumor cells: study
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, ...
Cancer Jun 13, 2012 | 4 / 5 (1) | 0 |
A collaborative research team from Boston University School of Medicine (BUSM), the Uniformed Services University of the Health Sciences (USU), the University of Texas Medical Branch (UTMB) and Galveston National ...
Medical research Oct 19, 2011 | 5 / 5 (1) | 0 |
A paper published today in the scientific research journal Science, describes a novel, proprietary monoclonal antibody (FI6) discovered in a collaboration between Humabs BioMed SA, the Institute for Research in Biomedicine ("IRB" ...
Medical research Jul 28, 2011 | 5 / 5 (1) | 0 |
(Medical Xpress)—Scientists studying the brain scans of chronic fatigue patients have found they use additional brain regions to do simple tasks requiring attention. This may explain the problems many sufferers ...
Diseases, Conditions, Syndromes Apr 23, 2013 | 5 / 5 (1) | 0
A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.
Cancer May 02, 2013 | not rated yet | 0
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as medications, the generic drug name ends in -mab (see "Nomenclature of monoclonal antibodies").
For more information about Monoclonal antibodies, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.